{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:53:35Z","timestamp":1789566815354,"version":"build-2803163510"},"reference-count":17,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2019,3,31]],"date-time":"2019-03-31T00:00:00Z","timestamp":1553990400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"the Centre Hospitalier Universitaire de Nice","award":["14-AOI-05"],"award-info":[{"award-number":["14-AOI-05"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8,1]]},"DOI":"10.1093\/ndt\/gfz041","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T07:27:01Z","timestamp":1549351621000},"page":"1423-1425","source":"Crossref","is-referenced-by-count":61,"title":["Rituximab bioavailability in primary membranous nephropathy"],"prefix":"10.1093","volume":"34","author":[{"given":"Sonia","family":"Boyer-Suavet","sequence":"first","affiliation":[{"name":"Service de N\u00e9phrologie-Dialyse-Transplantation, H\u00f4pital Pasteur, CHU de Nice, Universit\u00e9 de Nice-Sophia Antipolis, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Andreani","sequence":"additional","affiliation":[{"name":"Service de N\u00e9phrologie-Dialyse-Transplantation, H\u00f4pital Pasteur, CHU de Nice, Universit\u00e9 de Nice-Sophia Antipolis, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Cremoni","sequence":"additional","affiliation":[{"name":"Laboratoire d\u2019Immunologie, H\u00f4pital l\u2019Archet, CHU de Nice, Universit\u00e9 de Nice-Sophia Antipolis, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Brglez","sequence":"additional","affiliation":[{"name":"Service de N\u00e9phrologie-Dialyse-Transplantation, H\u00f4pital Pasteur, CHU de Nice, Universit\u00e9 de Nice-Sophia Antipolis, Nice, France"},{"name":"Laboratoire d\u2019Immunologie, H\u00f4pital l\u2019Archet, CHU de Nice, Universit\u00e9 de Nice-Sophia Antipolis, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Benzaken","sequence":"additional","affiliation":[{"name":"Laboratoire d\u2019Immunologie, H\u00f4pital l\u2019Archet, CHU de Nice, Universit\u00e9 de Nice-Sophia Antipolis, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghislaine","family":"Bernard","sequence":"additional","affiliation":[{"name":"Laboratoire d\u2019Immunologie, H\u00f4pital l\u2019Archet, CHU de Nice, Universit\u00e9 de Nice-Sophia Antipolis, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Nachman","sequence":"additional","affiliation":[{"name":"Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Esnault","sequence":"additional","affiliation":[{"name":"Service de N\u00e9phrologie-Dialyse-Transplantation, H\u00f4pital Pasteur, CHU de Nice, Universit\u00e9 de Nice-Sophia Antipolis, Nice, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Seitz-Polski","sequence":"additional","affiliation":[{"name":"Service de N\u00e9phrologie-Dialyse-Transplantation, H\u00f4pital Pasteur, CHU de Nice, Universit\u00e9 de Nice-Sophia Antipolis, Nice, France"},{"name":"Laboratoire d\u2019Immunologie, H\u00f4pital l\u2019Archet, CHU de Nice, Universit\u00e9 de Nice-Sophia Antipolis, Nice, France"},{"name":"CNRS and Universit\u00e9 de Nice-Sophia Antipolis, Institut de Pharmacologie Mol\u00e9culaire et Cellulaire, UMR 7275, Valbonne Sophia-Antipolis, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,3,30]]},"reference":[{"key":"2019080503545527500_gfz041-B1","first-page":"S1","article-title":"Mechanism of action of rituximab","volume":"12 (Suppl 2)","author":"Maloney","year":"2001","journal-title":"Anticancer Drugs"},{"key":"2019080503545527500_gfz041-B2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3324\/haematol.2008.001628","article-title":"Anti-CD20 monoclonal antibodies: historical and future perspectives","volume":"95","author":"Lim","year":"2010","journal-title":"Haematologica"},{"key":"2019080503545527500_gfz041-B3","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(02)11042-7","article-title":"Rituximab for idiopathic membranous nephropathy","volume":"360","author":"Remuzzi","year":"2002","journal-title":"Lancet"},{"key":"2019080503545527500_gfz041-B4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/sj.ki.5002628","article-title":"Rituximab treatment of idiopathic membranous nephropathy","volume":"73","author":"Fervenza","year":"2008","journal-title":"Kidney Int"},{"key":"2019080503545527500_gfz041-B5","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.2215\/CJN.05080610","article-title":"Rituximab therapy in idiopathic membranous nephropathy: a 2-year study","volume":"5","author":"Fervenza","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"2019080503545527500_gfz041-B6","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1681\/ASN.2010111125","article-title":"Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy","volume":"22","author":"Beck","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"2019080503545527500_gfz041-B7","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1681\/ASN.2016040449","article-title":"Rituximab for severe membranous nephropathy: A 6-month trial with extended follow-up","volume":"28","author":"Dahan","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2019080503545527500_gfz041-B8","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1681\/ASN.2016091022","article-title":"Safety of rituximab compared with steroids and cyclophosphamide for idiopathic membranous nephropathy","volume":"28","author":"van den Brand","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"2019080503545527500_gfz041-B9","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1136\/ard.2007.083162","article-title":"Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus","volume":"67","author":"Albert","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"2019080503545527500_gfz041-B10","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/rheumatology\/ket004","article-title":"Serum rituximab levels and efficiency of B cell depletion: differences between patients with rheumatoid arthritis and systemic lupus erythematosus","volume":"52","author":"Reddy","year":"2013","journal-title":"Rheumatology"},{"key":"2019080503545527500_gfz041-B11","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/ard.2009.109041","article-title":"Clinical response, pharmacokinetics, development of human anti-chimaeric antibodies, and synovial tissue response to rituximab treatment in patients with rheumatoid arthritis","volume":"69","author":"Thurlings","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"2019080503545527500_gfz041-B12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1158\/1078-0432.CCR-10-1292","article-title":"Interindividual variability of response to rituximab: from biological origins to individualized therapies","volume":"17","author":"Cartron","year":"2011","journal-title":"Clin Cancer Res"},{"key":"2019080503545527500_gfz041-B13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jim.2017.09.001","article-title":"Detection and quantification of rituximab in the human urine","volume":"451","author":"Jacobs","year":"2017","journal-title":"J Immunol Methods"},{"key":"2019080503545527500_gfz041-B14","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/annonc\/mdg175","article-title":"An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab","volume":"14","author":"Boye","year":"2003","journal-title":"Ann Oncol"},{"key":"2019080503545527500_gfz041-B15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1182\/blood.V97.1.101","article-title":"Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation","volume":"97","author":"Colombat","year":"2001","journal-title":"Blood"},{"key":"2019080503545527500_gfz041-B16","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V99.3.754","article-title":"Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene","volume":"99","author":"Cartron","year":"2002","journal-title":"Blood"},{"key":"2019080503545527500_gfz041-B17","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1681\/ASN.2017070734","article-title":"Phospholipase A2 Receptor 1 epitope Spreading at baseline predicts reduced likelihood of remission of membranous nephropathy","volume":"29","author":"Seitz-Polski","year":"2018","journal-title":"J Am Soc Nephrol"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ndt\/article-pdf\/34\/8\/1423\/29096776\/gfz041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T03:55:53Z","timestamp":1564977353000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/article\/34\/8\/1423\/5423855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,30]]},"references-count":17,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,3,30]]},"published-print":{"date-parts":[[2019,8,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfz041","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,8]]},"published":{"date-parts":[[2019,3,30]]}}}